Key statistics
As of last trade Assembly Biosciences Inc (V7B:BER) traded at 14.60, -17.98% below its 52-week high of 17.80, set on Sep 23, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 14.60 |
---|---|
High | 14.60 |
Low | 14.60 |
Bid | 14.05 |
Offer | 15.15 |
Previous close | 14.70 |
Average volume | 1.90k |
---|---|
Shares outstanding | 6.35m |
Free float | 4.34m |
P/E (TTM) | -- |
Market cap | 101.53m USD |
EPS (TTM) | -9.32 USD |
Data delayed at least 15 minutes, as of Oct 10 2024 07:08 BST.
More ▼
Announcements
- Assembly Biosciences Reports Positive Interim Phase 1a Results from Clinical Trial Evaluating Long-Acting Helicase-Primase Inhibitor Candidate ABI-5366
- Assembly Biosciences Reports Second Quarter 2024 Financial Results and Recent Updates
- Assembly Biosciences Presents New Preclinical Data Highlighting Investigational Helicase-Primase Inhibitors at International Herpesvirus Workshop
- Assembly Biosciences Doses First Participant in Phase 1b Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 for the Treatment of Chronic Hepatitis B Virus Infection
- Assembly Biosciences Announces $12.6 Million in Equity Financings
- Assembly Biosciences Doses First Participant in Phase 1a/b Clinical Trial of Herpes Simplex Virus Helicase-Primase Inhibitor Candidate ABI-5366
- Assembly Biosciences Presents New Data Highlighting Hepatitis D Virus Entry Inhibitor ABI-6250 at the EASL Congress™ 2024
- Assembly Biosciences to Present Data at Upcoming International Herpesvirus Workshop and EASL Congress™ 2024
- Assembly Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights
- Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights
More ▼